Answers are grounded in this paper and cite their sources.
Current treatment therapeutic approach for tuberculosis is the administration of first line drugs in the form of tablets and capsules for 4-6 months however; this approach leads to sever adverse effect. Therefore, present study was designed to achieving local and sustained targeting of ant tuberculosis drugs in order to reduce dose n frequency. Nanoparticles (NPs) have been found to be potential targeted and controlled release drug delivery systems.
No takes yet. Share an insight, caveat, or question.
Chandni et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: